Home » Topics » Regulatory » Patents

Patents
RSS

vTv Therapeutics describes HK-2 inhibitors

Dec. 28, 2016

GlaxoSmithKline and University of Dundee describe antiparasitic agents

Dec. 27, 2016

Lead Pharma Cel Models and Sanofi disclose RORgamma modulators

Dec. 27, 2016

Bantam Pharmaceutical patents mRNA translation initiation inhibitors

Dec. 27, 2016

Pfizer discloses vanin-1 inhibitors

Dec. 27, 2016

Bristol-Myers Squibb presents apelin receptor agonists

Dec. 23, 2016

Chiesi Farmaceutici develops PDE4B inhibitors and/or muscarinic M3 receptor antagonists

Dec. 23, 2016

GemVax & KAEL patent TNF-alpha production inhibitors and TGF-beta inhibitors

Dec. 23, 2016

Chinese scientists develop CDK/cyclin inhibitors

Dec. 22, 2016

Orion describes alpha2C-adrenoceptor antagonists

Dec. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...